A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

Authors:

Abstract
No abstract available
Funding Information
  • Astex Pharmaceuticals

This publication has 14 references indexed in Scilit: